Login to Your Account



Financings Roundup

Below-Range Pricing Remains, Anacor's IPO Brings in $60M

By Tom Wall


Monday, November 29, 2010
Investors continued their unenthusiastic reaction to biotech IPOs with last week's initial public offering from Anacor Pharmaceuticals Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription